Satellos Bioscience Inc. SEC filings MSLE
Satellos Bioscience Inc. has 53 filings in SEC EDGAR's recent list, going back to Dec 17, 2007. Its latest annual report, Form 40-F, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 27, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 27, 2026 | Oct 27, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Oct 5, 2026 | Oct 5, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 24, 2026 | Sep 24, 2026 |
| 6-K | Current report (foreign issuer) | Sep 15, 2026 | Sep 15, 2026 |
| 6-K | Current report (foreign issuer) | Sep 9, 2026 | Sep 9, 2026 |
| 6-K | Current report (foreign issuer) | Sep 1, 2026 | Sep 1, 2026 |
| 6-K | Current report (foreign issuer) | Aug 14, 2026 | Aug 14, 2026 |
| SUPPL | Filing | Aug 14, 2026 | — |
| 6-K | Current report (foreign issuer) | Aug 13, 2026 | Jun 30, 2026 |
| F-X | Form f-x | Aug 11, 2026 | — |
| F-10 | Filing | Aug 11, 2026 | — |
| 6-K | Current report (foreign issuer) | Jul 8, 2026 | Jul 8, 2026 |
| 6-K | Current report (foreign issuer) | Jun 29, 2026 | Jun 29, 2026 |
| 6-K | Current report (foreign issuer) | Jun 25, 2026 | Jun 25, 2026 |
| 6-K | Current report (foreign issuer) | Jun 18, 2026 | Jun 17, 2026 |
| 6-K | Current report (foreign issuer) | Jun 17, 2026 | Jun 17, 2026 |
| 6-K | Current report (foreign issuer) | May 27, 2026 | May 27, 2026 |
| 6-K | Current report (foreign issuer) | May 20, 2026 | May 19, 2026 |
| 6-K | Current report (foreign issuer) | May 15, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Apr 9, 2026 | Apr 9, 2026 |
| S-8 | Employee stock plan registration | Mar 27, 2026 | — |
| 40-F | Annual report (Canadian issuer) | Mar 27, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 27, 2026 | Mar 27, 2026 |
| 6-K | Current report (foreign issuer) | Mar 10, 2026 | Mar 10, 2026 |
| 6-K | Current report (foreign issuer) | Feb 24, 2026 | Feb 24, 2026 |
| 6-K | Current report (foreign issuer) | Feb 19, 2026 | Feb 19, 2026 |
| 6-K | Current report (foreign issuer) | Feb 18, 2026 | Feb 18, 2026 |
| 6-K | Current report (foreign issuer) | Feb 17, 2026 | Feb 17, 2026 |
| 6-K | Current report (foreign issuer) | Feb 12, 2026 | Feb 10, 2026 |
| 6-K | Current report (foreign issuer) | Feb 10, 2026 | Feb 10, 2026 |
| 6-K | Current report (foreign issuer) | Feb 10, 2026 | Feb 9, 2026 |
| 6-K | Current report (foreign issuer) | Feb 6, 2026 | Feb 6, 2026 |
| SUPPL | Filing | Feb 6, 2026 | — |
| CERT | Filing | Feb 6, 2026 | — |
| 8-A12B | Filing | Feb 5, 2026 | — |
| F-X | Form f-x | Feb 5, 2026 | — |
| F-10 | Filing | Feb 5, 2026 | — |
| D | Filing | Jan 3, 2025 | — |
| D | Filing | May 25, 2023 | — |
| D | Filing | Sep 27, 2022 | — |
| D | Filing | Sep 10, 2019 | — |
| D | Filing | Mar 8, 2019 | — |
| D | Filing | Feb 5, 2014 | — |
| D/A | Filing | Nov 21, 2013 | — |
| D | Filing | Nov 15, 2011 | — |
| D/A | Filing | Dec 1, 2009 | — |
| D | Filing | Nov 6, 2009 | — |
| REGDEX | Auto-generated paper document | Mar 12, 2009 | — |
| REGDEX | Auto-generated paper document | Dec 17, 2007 | — |
Showing 51 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MSLE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Markham
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1421642
- Former names
- ICO THERAPEUTICS INC (until Sep 10, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.